出处
发表于 2025-3-28 16:24:45
http://reply.papertrans.cn/17/1642/164149/164149_41.png
averse
发表于 2025-3-28 19:10:41
Developing Learning Organizations, This indolent lymphoma is the second most common of all cutaneous T-cell lymphomas. It typically presents with solitary cutaneous and subcutaneous erythematous-to-violaceous papules and nodules. Although relapse after treatment is very common, patients are typically asymptomatic, and the vast major
地牢
发表于 2025-3-28 23:13:35
http://reply.papertrans.cn/17/1642/164149/164149_43.png
不透气
发表于 2025-3-29 06:09:05
http://reply.papertrans.cn/17/1642/164149/164149_44.png
聚集
发表于 2025-3-29 08:44:21
http://reply.papertrans.cn/17/1642/164149/164149_45.png
PURG
发表于 2025-3-29 11:41:00
The Rules of the Game Have Changed,provisional entity in the World Health Organization–European Organization for Research and Treatment of Cancer (WHO/EORTC) guidelines and is considered to have both indolent and aggressive forms. pcSMPTCL typically presents with a persistent, asymptomatic, solitary erythematous nodule or pink plaque
Hyaluronic-Acid
发表于 2025-3-29 18:21:04
http://reply.papertrans.cn/17/1642/164149/164149_47.png
伦理学
发表于 2025-3-29 20:21:01
Allam Hamdan,Arezou Harraf,Hala Alsabatinors. It has an excellent prognosis. This entity has also been known as cutaneous marginal zone lymphoma (CMZL), extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MZL or MALT lymphoma), primary cutaneous immunocytoma, primary cutaneous plasmacytoma, and lymphoma cutis . Th
–LOUS
发表于 2025-3-30 00:31:29
Sayda Ben Sghaier,Rafaa Mraihi,Arij Lahmarenter B cells constitutes 60 % of all primary cutaneous B-cell lymphomas and 9–11 % of all cutaneous lymphomas . It also includes 5 % of all follicular lymphomas, nodal and extranodal . It typically presents with firm, erythematous to violaceous papules, plaques, and tumors on the scalp, tr
Axon895
发表于 2025-3-30 07:51:22
Quality Management System Audit,cally presents on the leg with erythematous or violaceous tumors or nodules, it can also present elsewhere on the body. Patients with pcDLBCL have a moderately poor prognosis and experience frequent systemic dissemination. Though small case series have reported dramatic improvements in survival with